VEGFR-2 pTyr1054/1059 (Human) antibody
Overview
|
|
| Antigen: | FLK-1/KDR/VEGFR-2 pTyr1054/pTyr1059 |
| Antibody Type: | Polyclonal |
| Application: | Western Blotting (WB) |
| Reactivity: | Human, Mouse (Murine), Rat |
| Host: | Rabbit |
| Quantity: | |
| Price: | 516,61 $ (Plus shipping costs and VAT, Invoice in EUR) |
| Order number: | ABIN113901 |
| Availability: | 3 to 10 days until shipment |
Additional Information: VEGFR-2 pTyr1054/1059 (Human) antibody
| Antigen | FLK-1/KDR/VEGFR-2 pTyr1054/pTyr1059 |
| Immunogen | Synthetic phosphopeptide derived from the region of human VEGFR2 |
| Reactivity | Human, Mouse (Murine), Rat |
| Antibody Type | Polyclonal |
| Format | Aff - Purified |
| Host | Rabbit |
| Specificity | Vascular Endothelial Growth Factor Receptor 2 (VEGFR2, also known as KDR/FLK-1) is a ~200 kDa member of a receptor tyrosine kinase family whose activation plays an essential role in a large number of biological processes such as embryonic development, wound healing, cell proliferation, migration, and differentiation. Like other growth factor receptors upon ligand binding, VEGFR2 forms a dimer and is autophosphorylated on multiple tyrosine residues. These sites can be involved in the regulation of kinase activity or serve as binding sites for SH2- and phosphotyrosine binding domain containing signaling proteins. Phosphorylation of tyrosines 1054 and 1059 in the activation loop is required for activation of VEGFR2 and its intrinsic tyrosine kinase activity. This antibody has been tested on Mouse VEGFR2. Human and rat (100% homologous) VEGFR2 have not been tested but are expected to react. VEGFR3 (100% homologous) has not been tested but is expected to react. |
Application Details: VEGFR-2 pTyr1054/1059 (Human) antibody
| Application | Western Blotting (WB) |
| Application Notes | Western blotting Recommended starting dilution: 1:1000 Optimal dilutions of this antibody are dependent on application and should be determined by the user. Positive controls used: Porcine aortic endothelial (PAE) cells transfected with a chimeric receptor consisting of the extracellular portion of the CSF-1 receptor fused with the transmembrane and intracellular domains of mouse VEGFR2 |
| Concentration | 0.5 mg/ml |
| Buffer | This antibody is supplied as purified IgG in Dulbecco’s phosphate buffered saline (without Mg2+ and Ca2+), pH 7.3 (+/- 0.1),50% glycerol, with 1.0 mg/mL BSA containg 0.05% sodium azide. The antibody was purified from rabbit serum by sequential epitope-spe |
| Storage | Store the antibody at -20°C. We recommend a brief centrifugation before opening to settle vial contents. Then, apportion into aliquots and freeze. For short-term storage up to one week, 2-8°C is sufficient. Avoid repeated freezing and thawing. Shelf life: one year from despatch. |
| Research Area | Cytokines, Receptors, Phospho-specific antibodies |
| Restrictions | For Research Use only |
Publications: VEGFR-2 pTyr1054/1059 (Human) antibody
| Publications |
Concejero, Chen, Wang et al.: "Living donor liver transplantation for hepatocellular carcinoma: a single-center experience in Taiwan." In: Transplantation , Vol. 85, Issue 3, pp. 398-406, 2008/01 (PubMed) |
Images: VEGFR-2 pTyr1054/1059 (Human) antibody
|
Peptide Competition and Stimulation.,.Extracts prepared from PAE cells transfected with a chimeric receptor (see Positive Controls section above for full description) were left unstimulated (1, 2) or stimulated with CSF (3-8), then were resolved by SDS-PAGE on a 10% polyacrylamide gel and transferred to PVDF. Membranes were blocked with a 5% BSA-TBST buffer overnight at 4oC, then were incubated with a VEGFR2 pan antibody (1, 3) or 0.50 ug/mL VEGFR2 [pYpY1054/1059] antibody for two hours at room temperature in a 3% BSA-TBST buffer, following prior incubation with: no peptide (2, 4, 5), the non-phosphopeptide corresponding to the immunogen (6), a generic phosphotyrosine containing peptide (7), or, the phosphopeptide immunogen (8). After washing, membranes were incubated with goat F(ab’)2 anti-rabbit IgG alkaline phosphatase and bands were detected using the Tropix WesternStar method. The data show that only the peptide corresponding to VEGFR2 [pYpY1054/1059] blocks the antibody signal, and the stimulation of the phospho signal after VEGF is added (compare lanes 2 and 4), thereby demonstrating the specificity of the antibody. Note that the chimeric CSF-1-VEGFR2 is ~190 kDa. |
External Information: VEGFR-2 pTyr1054/1059 (Human) antibody
| Google Scholar | Find more references for antigen FLK-1/KDR/VEGFR-2 pTyr1054/pTyr1059 on Google Scholar™ |
| EMBL Harvester | Search human, mouse or rat genome for antigen FLK-1/KDR/VEGFR-2 pTyr1054/pTyr1059 (Bioinformatic Harvester (EMBL)) |








